{"transactions":[{"id":1919082,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-17T19:24:09.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":false,"shares":112219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original option grant vested as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter."}],"balance_after":169900,"derivative":{"exercise_price":4.37,"expiration_date":"2031-05-16","underlying":"Common Stock","underlying_shares":112219},"source":{"system":"sec-edgar","filing":"0001062993-23-009245","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299323009245/form4.xml","form_type":"4"}},{"id":1919081,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-17T19:24:09.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":7781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original option grant vested as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter."}],"balance_after":282119,"derivative":{"exercise_price":4.37,"expiration_date":"2031-05-16","underlying":"Common Stock","underlying_shares":7781},"source":{"system":"sec-edgar","filing":"0001062993-23-009245","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299323009245/form4.xml","form_type":"4"}},{"id":1919080,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-04-17T19:24:09.000Z","date":"2023-04-17","kind":"sale","planned":false,"acquired":false,"shares":112219,"price":9.5397,"value":1070535.5943,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.80, inclusive. The reporting person undertakes to provide to CymaBay Therapeutics, Inc., any security holder of CymaBay Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001062993-23-009245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299323009245/form4.xml","form_type":"4"}},{"id":1919079,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-04-17T19:24:09.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":true,"shares":112219,"price":4.37,"value":490397.03,"ownership":{"direct":true},"balance_after":132219,"source":{"system":"sec-edgar","filing":"0001062993-23-009245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299323009245/form4.xml","form_type":"4"}},{"id":1919078,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-04-17T19:24:09.000Z","date":"2023-04-13","kind":"sale","planned":false,"acquired":false,"shares":7781,"price":8.9809,"value":69880.3829,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.98 to $8.985, inclusive. The reporting person undertakes to provide to CymaBay Therapeutics, Inc., any security holder of CymaBay Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001062993-23-009245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299323009245/form4.xml","form_type":"4"}},{"id":1919077,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-04-17T19:24:09.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":7781,"price":4.37,"value":34002.97,"ownership":{"direct":true},"balance_after":27781,"source":{"system":"sec-edgar","filing":"0001062993-23-009245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299323009245/form4.xml","form_type":"4"}},{"id":1935160,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-30T17:39:49.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The original option grant vested as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter."}],"balance_after":289900,"derivative":{"exercise_price":4.37,"expiration_date":"2031-05-16","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001062993-23-008102","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299323008102/form4.xml","form_type":"4"}},{"id":1935159,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-30T17:39:49.000Z","date":"2023-03-28","kind":"sale","planned":false,"acquired":false,"shares":100,"price":8.985,"value":898.5,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001062993-23-008102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299323008102/form4.xml","form_type":"4"}},{"id":1935158,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-30T17:39:49.000Z","date":"2023-03-28","kind":"exercise","planned":false,"acquired":true,"shares":100,"price":4.37,"value":437.0,"ownership":{"direct":true},"balance_after":20100,"source":{"system":"sec-edgar","filing":"0001062993-23-008102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299323008102/form4.xml","form_type":"4"}},{"id":2043968,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-27T16:30:11.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2023."}],"balance_after":180000,"derivative":{"exercise_price":7.8,"expiration_date":"2033-01-24","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001062993-23-001494","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299323001494/form4.xml","form_type":"4"}},{"id":2424288,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-27T16:56:02.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":133333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2022."}],"balance_after":133333,"derivative":{"exercise_price":2.94,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":133333},"source":{"system":"sec-edgar","filing":"0001062993-22-001699","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299322001699/form4.xml","form_type":"4"}},{"id":2431116,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-20T16:35:19.000Z","date":"2022-01-19","kind":"purchase","acquired":true,"shares":20000,"price":3.04,"value":60800.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001062993-22-001295","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299322001295/form4.xml","form_type":"4"}},{"id":2710729,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-17T18:57:47.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter."}],"balance_after":10000,"derivative":{"exercise_price":4.37,"expiration_date":"2031-05-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001062993-21-004767","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299321004767/form4.xml","form_type":"4"}},{"id":2710728,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-17T18:57:47.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":390000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter."}],"balance_after":390000,"derivative":{"exercise_price":4.37,"expiration_date":"2031-05-16","underlying":"Common Stock","underlying_shares":390000},"source":{"system":"sec-edgar","filing":"0001062993-21-004767","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000106299321004767/form4.xml","form_type":"4"}},{"id":3061814,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-08-11T14:51:51.000Z","date":"2020-08-07","kind":"grant","acquired":true,"shares":4000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each of the Options shall be exercisable for a price of $0.045 per Option Share for ten years from August 7, 2020 (the \"Grant Date\") and all Options will vest 10% on the Grant Date and 90% in equal semiannual installments over four years."}],"balance_after":4736541,"derivative":{"exercise_price":0.045,"expiration_date":"2030-08-07","underlying":"Common Stock","underlying_shares":4000000},"source":{"system":"sec-edgar","filing":"0001640334-20-002025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1456750/000164033420002025/form4.xml","form_type":"4"}},{"id":3688024,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-24T20:25:08.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vests on January 22, 2020, and the remainder vests in equal monthly installments thereafter over 36 months."}],"balance_after":95000,"derivative":{"exercise_price":4.63,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0000899243-19-001926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1456750/000089924319001926/doc4.xml","form_type":"4"}},{"id":4036864,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-23T17:06:23.000Z","date":"2018-02-22","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vests on February 22, 2019, and the remainder vests in equal monthly installments thereafter over 36 months"}],"balance_after":125000,"derivative":{"exercise_price":7.77,"expiration_date":"2028-02-22","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-18-005337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1456750/000089924318005337/doc4.xml","form_type":"4"}},{"id":4258373,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-12T16:05:24.000Z","date":"2017-07-11","kind":"purchase","acquired":true,"shares":10000,"price":3.39,"value":33900.0,"ownership":{"direct":true},"balance_after":21443,"source":{"system":"sec-edgar","filing":"0000899243-17-018210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1456750/000089924317018210/doc4.xml","form_type":"4"}},{"id":4324623,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-05-11T18:59:26.000Z","date":"2017-05-11","kind":"purchase","acquired":true,"shares":9800,"price":4.4,"value":43120.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 646 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan (the \"Plan\") on January 1, 2015, 699 shares acquired under the Plan on July 1, 2015 and 98 shares acquired under the Plan on January 1, 2016."}],"balance_after":11443,"source":{"system":"sec-edgar","filing":"0000899243-17-012901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1456750/000089924317012901/doc4.xml","form_type":"4"}},{"id":4324622,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-05-11T18:59:26.000Z","date":"2017-05-10","kind":"purchase","acquired":true,"shares":200,"price":4.4,"value":880.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 646 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan (the \"Plan\") on January 1, 2015, 699 shares acquired under the Plan on July 1, 2015 and 98 shares acquired under the Plan on January 1, 2016."}],"balance_after":1643,"source":{"system":"sec-edgar","filing":"0000899243-17-012901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1456750/000089924317012901/doc4.xml","form_type":"4"}},{"id":4475259,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":114421,"kind":"person","name":"KIM DENNIS D","position":1,"cik":"0001456750","reported_name":"KIM DENNIS D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-31T17:31:24.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":88000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vests on January 27, 2018, and the remainder vests in equal monthly installments thereafter over 36 months."}],"balance_after":88000,"derivative":{"exercise_price":4.05,"expiration_date":"2027-01-27","underlying":"Common Stock","underlying_shares":88000},"source":{"system":"sec-edgar","filing":"0000899243-17-002287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1456750/000089924317002287/doc4.xml","form_type":"4"}}]}